STUDENTS WELCOME EXPANSION OF THE COMMONWEALTH PRAC PAYMENT
Cost of living relief for students training in national skills shortage fields
With
Dr Rik Dawson,
APA Gerontological Physiotherapist &
National President,
Australian Physiotherapy Association (APA) &
Postdoctoral Researcher
Institute for Musculoskeletal Health,
University of Sydney
Jianqi Li, new graduate physiotherapist
Early Career Representative, Australian Physiotherapy Association
Benjamin Tze Yong Ong, Final-year physiotherapy student,
University of Queensland & APA National Student Representative
Mia Avram
Fourth-year pharmacy student at Monash University &
National President,
National Australian Pharmacy Students’ Association (NAPSA)
Divya Lal, Community Pharmacist &
NSW/ACT State Manager,
Pharmaceutical Society of Australia (PSA)
SEGMENT
Filmed in Sydney & Brisbane | August 2026
The Australian Government is expanding the Commonwealth Prac Payment to eligible students in 10 additional frontline allied health disciplines, providing financial support during mandatory university placements.
From 1 July 2027, eligible students studying audiology, pharmacy, radiography, clinical psychology, physiotherapy, rehabilitation therapies, occupational therapy, podiatry, speech pathology and paramedicine will be able to access the payment.
The expansion builds on the payment currently available to eligible teaching, nursing, midwifery and social work students, and is expected to support around 95,000 students each year, including an additional 21,000 higher education students in frontline allied health courses.
The Government says the initiative will help address workforce shortages by supporting students to complete their studies and enter frontline health professions, particularly in areas such as primary care, hospitals, aged care, disability and regional communities.
Australian Health Journal spoke with representatives of two industry bodies who lobbied for the expansion, Australian Physiotherapy Association (APA) & Pharmaceutical Society of Australia (PSA).
Source: Adapted from the “Expansion of the Commonwealth Prac Payment Factsheet”, July 2026, Department of Education, Australian Government
-
Investments to address health inequities in Prostate Cancer Care
Income, education, geographical location, and discrimination based on ethnicity, race, gender and sexual orientation, are only a fraction of factors that can negatively affect a person’s quality of cancer care. This is defined as the “equity gap” and it’s costing people their lives.
Timed to coincide with World Cancer Day 4th February 2025, Movember announced prostate cancer investment of $5.5 million. Eighteen grants (16 proposals and 2 community development grants) are slated to directly tackle inequities in prostate cancer care. The funding will be over three years with the grants spread across five countries – six in Canada, five in the United Kingdom, three in Australia, three in the United States and one in Ireland – each having a specific focus population and care area.
-
Global MedTech company brings device reprocessing plant to Australia
Cardinal Health is global medical products manufacturer and leading provider of single-use device reprocessing services in the U.S. In Australia and New Zealand, as one of the largest suppliers of medical devices, announced on 23 May 2024 that it will be opening a single-use medical device reprocessing facility in Australia – its first reprocessing facility outside the United States.
On 18 March 2025 at the Health Innovation Living Lab at the John Hunter Hospital, a further announcement was made, on the chosen single-use medical device remanufacturing facility in Beresfield, Newcastle, set to commence operation late 2025, supported by the NSW Department of Primary Industries and Regional Development.
-
Orthopaedic surgeon driven to understand & manage infection
In tandem with his clinical practice, Associate Professor Tetsworth is deeply engaged in orthopaedic research, with a keen interest in infection management, infection control, limb salvage, bone defect reconstruction, biomarker development for infection, bone growth hormone delivery, and the use of 3D printed models for reconstructing segmental bone defects.
